Conformis, Inc. to Participate in Upcoming Investor Conferences
February 25 2021 - 8:00AM
Conformis, Inc. (NASDAQ: CFMS), a leading medical device
company that features personalized knee and hip replacement
products, announced today that Mark Augusti, Chief Executive
Officer, and Bob Howe, Chief Financial Officer, will participate at
two upcoming virtual investor conferences.
March 4 – 41st
Annual Cowen Healthcare Conference
- The Cowen 41st Annual Healthcare Conference will take place
virtually March 1-4, 2021. Conformis management will participate in
a fireside chat on Thursday, March 4, 2021, from 9:50 a.m.
until 10:20 a.m. ET. A live webcast of the presentation will be
available at https://wsw.com/webcast/cowen81/cfms/1945101.
- Conformis management will also be available for one-on-one
meetings throughout the conference. For more information about the
conference or to schedule a one-on-one meeting with management,
please contact your Cowen representative or contact Conformis
Investor Relations at ir@conformis.com and (781) 374-5598.
March 17 – 31st Annual
Oppenheimer Healthcare Conference
- The Oppenheimer 31st Annual Healthcare Conference will take
place virtually March 16-18, 2021. Conformis management will
present on Wednesday, March 17, 2021, from 10:00 a.m. until
10:30 a.m. ET. A live webcast of the presentation will be available
at https://wsw.com/webcast/oppenheimer9/cfms/2708189.
- Conformis management will also be available for one-on-one
meetings throughout the conference. For more information about the
conference or to schedule a one-on-one meeting with management,
please contact your Oppenheimer representative or contact Conformis
Investor Relations at ir@conformis.com and (781) 374-5598.
A live webcast of each presentation will also be available under
"Events and Presentations" in the Investors section of the
Conformis website at ir.conformis.com. Replays of the webcasts will
be archived on Conformis' website for 30 days following the
presentations.
About Conformis, Inc.
Conformis is a medical technology company that uses its
proprietary iFit® Image-to-Implant® technology platform to develop,
manufacture, and sell joint replacement implants and instruments
that are individually sized and shaped, which we refer to as
personalized, individualized, or sometimes as customized, to fit
and conform to each patient’s unique anatomy. Conformis offers
a broad line of sterile, personalized knee and hip implants and
single-use instruments delivered to hospitals and ambulatory
surgical centers. Conformis owns or exclusively in-licenses issued
patents and pending patent applications that cover personalized
implants and patient-specific instrumentation for all major
joints.
For more information, visit www.conformis.com. To receive future
releases in e-mail alerts, sign up at http://ir.conformis.com.
Investor Contact:ir@conformis.com(781)
374-5598
Conformis (NASDAQ:CFMS)
Historical Stock Chart
From Aug 2024 to Sep 2024
Conformis (NASDAQ:CFMS)
Historical Stock Chart
From Sep 2023 to Sep 2024